Cellebrite DI Ltd. Expected to Post FY2026 Earnings of $0.54 Per Share (NASDAQ:CLBT)

Cellebrite DI Ltd. (NASDAQ:CLBT) – Analysts at William Blair raised their FY2026 earnings per share estimates for shares of Cellebrite DI in a report issued on Thursday, August 15th. William Blair analyst J. Ho now expects that the company will post earnings of $0.54 per share for the year, up from their prior forecast of $0.53. The consensus estimate for Cellebrite DI’s current full-year earnings is $0.38 per share. William Blair also issued estimates for Cellebrite DI’s FY2027 earnings at $0.62 EPS and FY2028 earnings at $0.72 EPS.

Cellebrite DI (NASDAQ:CLBT) last posted its earnings results on Thursday, August 15th. The company reported $0.10 earnings per share for the quarter, beating analysts’ consensus estimates of $0.08 by $0.02. Cellebrite DI had a negative net margin of 28.51% and a positive return on equity of 515.14%. The firm had revenue of $95.70 million during the quarter, compared to analyst estimates of $91.94 million. During the same period last year, the firm posted $0.05 earnings per share. Cellebrite DI’s revenue for the quarter was up 24.8% compared to the same quarter last year.

Several other research analysts have also commented on CLBT. Bank of America lifted their price target on Cellebrite DI from $13.00 to $17.00 and gave the stock a “buy” rating in a research report on Friday, August 16th. JPMorgan Chase & Co. boosted their target price on Cellebrite DI from $14.00 to $15.00 and gave the company an “overweight” rating in a research report on Wednesday, August 14th. Needham & Company LLC increased their price target on Cellebrite DI from $14.00 to $17.00 and gave the company a “buy” rating in a report on Friday, August 16th. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Cellebrite DI from $15.00 to $18.00 and gave the stock a “buy” rating in a research note on Friday, August 16th. Finally, Lake Street Capital increased their target price on shares of Cellebrite DI from $13.50 to $17.00 and gave the company a “buy” rating in a research note on Friday, August 16th. Seven research analysts have rated the stock with a buy rating, According to MarketBeat.com, Cellebrite DI currently has a consensus rating of “Buy” and a consensus target price of $17.33.

Cellebrite DI Stock Up 2.5 %

Cellebrite DI stock opened at $16.78 on Monday. The company’s 50-day moving average price is $12.85 and its 200-day moving average price is $11.69. The company has a market cap of $3.46 billion, a PE ratio of -28.93, a price-to-earnings-growth ratio of 1.97 and a beta of 1.50. Cellebrite DI has a twelve month low of $6.36 and a twelve month high of $16.89.

Hedge Funds Weigh In On Cellebrite DI

Several hedge funds have recently bought and sold shares of the business. IGP Investments G.P.L.P LP purchased a new stake in shares of Cellebrite DI during the fourth quarter valued at $182,619,000. Pembroke Management LTD boosted its position in Cellebrite DI by 104.9% in the 2nd quarter. Pembroke Management LTD now owns 1,535,726 shares of the company’s stock valued at $18,352,000 after buying an additional 786,310 shares during the period. Scalar Gauge Management LLC bought a new position in Cellebrite DI in the 4th quarter worth about $5,914,000. Acadian Asset Management LLC increased its position in shares of Cellebrite DI by 26.8% during the first quarter. Acadian Asset Management LLC now owns 2,896,497 shares of the company’s stock worth $32,062,000 after acquiring an additional 612,787 shares during the period. Finally, Clal Insurance Enterprises Holdings Ltd raised its stake in shares of Cellebrite DI by 7.8% during the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 7,086,158 shares of the company’s stock valued at $56,446,000 after acquiring an additional 514,858 shares in the last quarter. Institutional investors own 45.88% of the company’s stock.

Cellebrite DI Company Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.